- Home
- LGCY vs MODD Comparison
LGCY vs MODD Comparison
Compare LGCY & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCY
- MODD
- Stock Information
- Founded
- LGCY 2009
- MODD 1998
- Country
- LGCY United States
- MODD United States
- Employees
- LGCY N/A
- MODD 40
- Industry
- LGCY
- MODD Industrial Specialties
- Sector
- LGCY
- MODD Health Care
- Exchange
- LGCY NYSE
- MODD Nasdaq
- Market Cap
- LGCY 67.3M
- MODD 67.4M
- IPO Year
- LGCY 2024
- MODD N/A
- Fundamental
- Price
- LGCY $5.77
- MODD $2.07
- Analyst Decision
- LGCY Strong Buy
- MODD Buy
- Analyst Count
- LGCY 2
- MODD 1
- Target Price
- LGCY $8.48
- MODD $5.00
- AVG Volume (30 Days)
- LGCY 65.8K
- MODD 98.7K
- Earning Date
- LGCY 11-14-2024
- MODD 11-26-2024
- Dividend Yield
- LGCY N/A
- MODD N/A
- EPS Growth
- LGCY 90.87
- MODD N/A
- EPS
- LGCY 0.63
- MODD N/A
- Revenue
- LGCY $49,638,473.00
- MODD N/A
- Revenue This Year
- LGCY N/A
- MODD N/A
- Revenue Next Year
- LGCY N/A
- MODD $830.43
- P/E Ratio
- LGCY $10.34
- MODD N/A
- Revenue Growth
- LGCY 32.36
- MODD N/A
- 52 Week Low
- LGCY $3.60
- MODD $1.00
- 52 Week High
- LGCY $7.83
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- LGCY N/A
- MODD 38.24
- Support Level
- LGCY N/A
- MODD $2.15
- Resistance Level
- LGCY N/A
- MODD $2.34
- Average True Range (ATR)
- LGCY 0.00
- MODD 0.12
- MACD
- LGCY 0.00
- MODD -0.02
- Stochastic Oscillator
- LGCY 0.00
- MODD 6.25
About LGCY LEGACY EDUCATION INC
Legacy Education Inc is engaged in career-focused, post-secondary education services to students at all stages of adult life, from recent high school graduates to working parents.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.